Breaching the Blood-brain Barrier: AAV Triggers Dose-dependent Toxicity in the Brain

Overview

Journal Mol Ther Methods Clin Dev

Publisher Cell Press

Date 2023 Sep 27

PMID 37753219

Authors

Daniel Stone

Martine Aubert

Keith R Jerome

Affiliations

Soon will be listed here.

Citing Articles

Advances in RNA-Based Therapeutics: Challenges and Innovations in RNA Delivery Systems.

Liu Y, Ou Y, Hou L Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852137 PMC: 11763986. DOI: 10.3390/cimb47010022.

HDI-STARR-seq: Condition-specific enhancer discovery in mouse liver in vivo.

Chang T, Waxman D BMC Genomics. 2024; 25(1):1240.

PMID: 39716078 PMC: 11668083. DOI: 10.1186/s12864-024-11162-9.

The opportunities and challenges of epigenetic approaches to manage herpes simplex infections.

Saddoris S, Schang L Expert Rev Anti Infect Ther. 2024; 22(12):1123-1142.

PMID: 39466139 PMC: 11634640. DOI: 10.1080/14787210.2024.2420329.

HDI-STARR-seq: Condition-specific enhancer discovery in mouse liver in vivo.

Chang T, Waxman D bioRxiv. 2024; .

PMID: 38915578 PMC: 11195054. DOI: 10.1101/2024.06.10.598329.

In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignancies.

Song Z, Liu P, Zhang D, Wang T, Yue W, Geng Y Blood Cancer J. 2024; 14(1):46.

PMID: 38485926 PMC: 10940594. DOI: 10.1038/s41408-024-01036-4.

References

Guo Y, Chen J, Ji W, Xu L, Xie Y, He S . High-titer AAV disrupts cerebrovascular integrity and induces lymphocyte infiltration in adult mouse brain. Mol Ther Methods Clin Dev. 2023; 31:101102. PMC: 10518493. DOI: 10.1016/j.omtm.2023.08.021. View

Hordeaux J, Buza E, Jeffrey B, Song C, Jahan T, Yuan Y . MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates. Sci Transl Med. 2020; 12(569). DOI: 10.1126/scitranslmed.aba9188. View

Samaranch L, San Sebastian W, Kells A, Salegio E, Heller G, Bringas J . AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction. Mol Ther. 2014; 22(2):329-337. PMC: 3918916. DOI: 10.1038/mt.2013.266. View

Klein R, Dayton R, Leidenheimer N, Jansen K, Golde T, Zweig R . Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Mol Ther. 2005; 13(3):517-27. PMC: 2987642. DOI: 10.1016/j.ymthe.2005.10.008. View

Hordeaux J, Buza E, Dyer C, Goode T, Mitchell T, Richman L . Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology. Hum Gene Ther. 2020; 31(15-16):808-818. DOI: 10.1089/hum.2020.167. View

Golebiowski D, van der Bom I, Kwon C, Miller A, Petrosky K, Bradbury A . Direct Intracranial Injection of AAVrh8 Encoding Monkey β-N-Acetylhexosaminidase Causes Neurotoxicity in the Primate Brain. Hum Gene Ther. 2017; 28(6):510-522. PMC: 5488349. DOI: 10.1089/hum.2016.109. View

Keiser M, Ranum P, Yrigollen C, Carrell E, Smith G, Muehlmatt A . Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain. Nat Med. 2021; 27(11):1982-1989. PMC: 8605996. DOI: 10.1038/s41591-021-01522-3. View

Sondhi D, Kaminsky S, Hackett N, Pagovich O, Rosenberg J, De B . Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing . Sci Transl Med. 2020; 12(572). PMC: 8056991. DOI: 10.1126/scitranslmed.abb5413. View

Rosenberg J, Chen A, De B, Dyke J, Ballon D, Monette S . Safety of Direct Intraparenchymal AAVrh.10-Mediated Central Nervous System Gene Therapy for Metachromatic Leukodystrophy. Hum Gene Ther. 2020; 32(11-12):563-580. PMC: 8236561. DOI: 10.1089/hum.2020.269. View

10.

Johnston S, Parylak S, Kim S, Mac N, Lim C, Gallina I . AAV ablates neurogenesis in the adult murine hippocampus. Elife. 2021; 10. PMC: 8331179. DOI: 10.7554/eLife.59291. View

11.

Kaplitt M, Leone P, Samulski R, Xiao X, Pfaff D, OMalley K . Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet. 1994; 8(2):148-54. DOI: 10.1038/ng1094-148. View

12.

Peters C, Maguire C, Hanlon K . Delivering AAV to the Central Nervous and Sensory Systems. Trends Pharmacol Sci. 2021; 42(6):461-474. PMC: 9302199. DOI: 10.1016/j.tips.2021.03.004. View

13.

Stone D, Aubert M, Jerome K . Adeno-associated virus vectors and neurotoxicity-lessons from preclinical and human studies. Gene Ther. 2023; 32(1):60-73. PMC: 11247785. DOI: 10.1038/s41434-023-00405-1. View